Fig. 1From: Effect of bixalomer on coronary artery calcification in hemodialysis patients with hyperphosphatemia: a multi-center, randomized controlled trialPatient disposition. aThe number of patients who initiated or restarted lanthanum carbonate treatment was 21 in the bixalomer group and 19 in the calcium carbonate group. In the bixalomer group, the “Other” reason for discontinuation in one patient was that the patient felt nausea. In the calcium carbonate group, the “Other” reason for discontinuation in one patient was that the patient was transferred for psychiatric reasonsBack to article page